Attorney Jessica Paluch-Hoerman, founder of TruLaw, has over 28 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.
This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.
TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.
Question: What are the long-term side effects of Depo Provera?
Depo Provera long term side effects include bone density loss, changes to the menstrual cycle, weight gain, and mood alterations.
The most serious long-term side effect of Depo Provera contraceptive injections is the development of meningioma brain tumors, with studies showing users are up to five times more likely to develop these tumors compared to non-users.
Our law firm is actively assisting individuals with Depo Provera lawsuit claims across all fifty (50) states in the United States.
This page provides the most current information about Depo Provera’s long-term health impacts and expert insights on legal options for those affected by these side effects.
You will not find more thorough information about Depo Provera long term side effects and health risks anywhere else.
On this page, we’ll examine what Depo-Provera is, known long-term side effects associated with Depo Provera birth control injectables, the connection to meningioma brain tumors, and much more.
Depo-Provera is an injectable form of birth control containing depot medroxyprogesterone acetate, a synthetic form of progesterone administered every three months.
Women across the country are discovering troubling health issues after years of using this birth control shot, with meningioma brain tumors emerging as the most alarming concern.
The primary long-term side effect being investigated in lawsuits is meningioma brain tumors.
Recent research published in 2024 found that women who used Depo-Provera for over a year face approximately five times higher risk of developing meningioma brain tumors compared to those not using the drug.
Medical experts now recognize that prolonged exposure to high doses of progestins (like those in Depo Provera shots) increases the risk of meningioma development, yet many users report never being warned about this possibility.
In addition to the meningioma risk, extended Depo-Provera use is associated with bone mineral density reduction (prompting an FDA black box warning), menstrual irregularities, weight gain, and mood changes.
If you or someone you love has been diagnosed with meningioma (brain tumors) after using Depo-Provera long acting injectable contraception, you may be eligible to seek compensation.
Contact TruLaw using the chat on this page to receive an instant case evaluation and determine whether you qualify to join others in filing a Depo-Provera lawsuit today.
Depo-Provera is a hormonal birth control injection given every three months.
Before discussing its long-term side effects, it’s helpful to know exactly what this medication is and how it functions in the body.
Depo-Provera contains depo medroxyprogesterone acetate, a synthetic form of the hormone progesterone.
Healthcare providers administer the injection into the arm or buttock muscle.
The injection delivers the hormone directly into the bloodstream, where it releases slowly over 12-14 weeks, requiring visits to a medical office four times per year.
With perfect use, Depo-Provera is 99.7% effective at preventing pregnancy.
The real-world effectiveness rate is approximately 94%, accounting for missed or delayed injections.
This contraceptive agent works through multiple mechanisms:
The FDA first approved Depo-Provera for contraceptive use in 1992.
Over the years, the FDA has updated the product labeling to include additional warnings about potential health impacts.
Currently, about 2-3 million women in the United States use this long acting injectable contraceptive method.
While the Depo injection offers effective birth control, its use beyond one year has been associated with various health concerns.
Women considering or currently using this method should be aware of these potential effects.
Depo-Provera can affect how the body absorbs calcium, which may lead to bone density reduction.
Studies show approximately 5-7% of users experience measurable bone mass decrease (especially young women), particularly in the hip and lower spine, which may be improved if patients exercise regularly.
The FDA has required Depo-Provera’s label to include a “black box” warning about possible bone mineral density loss from prolonged use.
These warnings indicate that it is unknown if using Depo-Provera during teen years or early adulthood affects bone strength later in life.
The drug’s prescribing information only advises long-term use if a patient is medically unable to use other birth control options.
Research indicates bone density often begins recovering after discontinuing the Depo Provera injections, though full recovery may take years.
Women with existing risk factors, including smoking, low calcium intake, or family history of osteoporosis, should discuss these concerns with their healthcare provider.
Extended use typically causes noticeable changes in menstrual bleeding patterns:
Research suggests Depo-Provera may influence glucose metabolism differently than other hormonal contraceptives.
Studies suggest users of Depo-Provera may experience more weight gain over time compared to those using oral contraceptives, though some users report weight loss, and individual experiences vary widely.
The hormonal changes initiated by Depo-Provera can stimulate appetite and alter metabolism, potentially causing individuals to gain weight.
This weight change appears it can also connected to:
Regular check-ins with healthcare providers can help monitor the effects outlined below.
Research indicates potential impacts on mental wellbeing, including (but not limited to):
Growing research indicates a possible connection between prolonged use of progestins (like those in Depo-Provera) and the development of meningioma brain tumors.
While generally benign, these tumors can cause serious health problems.
Meningiomas are tumors that form in the meninges, the protective layers surrounding the brain and spinal cord.
Recent studies have revealed that hormonal medications containing progestins may increase the risk of developing these tumors.
A March 2024 study found Depo-Provera users (for one year or more) faced a 5.6-fold increased risk of intracranial meningiomas requiring surgery.
A subsequent September 2024 study confirmed these concerns, finding 53% greater odds of developing meningioma in users compared to non-users.
Scientists believe that progestins may activate receptors in meningeal tissues, potentially stimulating abnormal cell growth.
Several factors influence meningioma risk levels when using medroxyprogesterone contraceptive injections, these include (but are not limited to):
Early detection of potential side effects in long-term Depo-Provera users is key to proper treatment.
Being aware of these symptoms can help users seek appropriate medical care promptly.
Various warning signs might indicate the presence of a meningioma:
Important: If you experience sudden, severe symptoms like intense headaches with vomiting or seizures, seek emergency medical attention immediately.
Women who have used Depo-Provera for multiple years should discuss bone density screening with their healthcare provider.
Bone health concerns may present as:
Regular appointments with healthcare providers can help track and address the concerns outlined below.
Pay attention to any of the following potential issues after you begin taking Depo-Provera birth control injections:
Pharmaceutical companies must warn users about potential risks associated with their products, including serious health issues.
When these warnings are inadequate, patients who suffer serious side effects may have legal options available.
Manufacturers have a duty to provide clear warnings about their products’ risks.
For Depo-Provera, this responsibility involves informing users about all potential health impacts, including rare but serious ones like meningiomas.
The FDA has required several label updates over the years, including:
However, many patients allege these warnings came too late or were insufficient, particularly regarding the risk of developing meningiomas.
TruLaw is actively accepting cases from patients who developed meningioma brain tumors after using Depo-Provera.
These lawsuits center on several key allegations:
Recent medical studies have strengthened these claims by demonstrating a dose-dependent relationship – the longer the use and higher the cumulative dose of progestin, the greater the risk of developing meningiomas.
In France, authorities suspended certain high-dose progestin medications in 2021 after studies showed a 7-fold increased risk of meningiomas with long-term use.
This regulatory action has bolstered similar claims in the United States regarding medroxyprogesterone contraceptive injections.
While lawsuits related to significant bone density loss and reproductive health complications have occurred previously, TruLaw is not currently accepting these types of cases.
Our focus remains exclusively on representing clients affected by meningiomas potentially linked to Depo-Provera use.
Patients diagnosed with meningiomas following Depo-Provera use may be eligible for various types of compensation:
The statute of limitations varies by state, typically ranging from 1-3 years after discovering an injury related to your contraceptive injection.
However, this can differ on a case by case basis – for that reason, it’s important to discuss the details of your situation with an experienced Depo Provera attorney.
They can help you understand how the statute of limitations will impact your case and ensure you do not miss any important deadlines.
At TruLaw, attorney Jessica Paluch-Hoerman specializes in pharmaceutical liability cases and can evaluate your situation if you’ve developed a meningioma after using Depo-Provera.
Our team works with medical experts to establish the connection between your diagnosis and medication use.
If you or a loved one developed a meningioma after using Depo-Provera, you may be eligible to seek compensation.
Contact TruLaw using the chat on this page to receive an instant case evaluation and determine whether you qualify to join others in filing a Depo-Provera lawsuit today.
Patients who have used Depo-Provera long-term should consider certain medical monitoring protocols.
Various alternative birth control methods exist for those concerned about the risks.
Women who have used Depo-Provera for extended periods should follow specific health screening recommendations.
The following monitoring protocols can help identify issues early, potentially improving treatment outcomes:
Early intervention typically leads to better outcomes.
Various interventions can address side effects:
Several options may offer effective pregnancy prevention with fewer long-term concerns.
You can discuss these alternatives with your healthcare providers to help decide what may be best for you.
Alternative birth control methods to consider include, but are not limited to:
Discovering a connection between health problems and medication can be overwhelming.
Here’s a structured approach to addressing these concerns.
Proper documentation strengthens both medical care and potential legal claims
This documentation becomes valuable for both medical treatments and any potential legal action.
Medical documentation may include, but is not limited to:
Various specialists can help address specific Depo Provera long term side effects:
When meeting with specialists, consider asking:
Patient advocacy groups can also provide resources and support during this process.
If you believe your health issues stem from Depo-Provera use (particularly meningioma development), consulting with an experienced Depo Provera lawyer at TruLaw is advised.
When seeking legal guidance:
Most pharmaceutical cases operate on contingency fees, meaning you pay nothing unless compensation is recovered.
The legal process typically takes 1-3 years, depending on case specifics and whether settlement is reached.
However, this can differ on a case by case basis – for that reason, it’s important to discuss the details of your situation with an experienced Depo Provera attorney.
They can help you understand what the timeline may look like for your case.
At TruLaw, attorney Jessica Paluch-Hoerman specializes in pharmaceutical liability cases and can evaluate your situation if you’ve developed a meningioma after using Depo-Provera.
Our team works with medical experts to establish the connection between your diagnosis and medication use.
If you or a loved one developed a meningioma after using Depo-Provera, you may be eligible to seek compensation.
Contact TruLaw using the chat on this page to receive an instant case evaluation and determine whether you qualify to join others in filing a Depo-Provera lawsuit today.
Depo-Provera lawsuits are being filed by individuals across the country who were diagnosed with meningioma or other severe health conditions after using the contraceptive injection.
TruLaw is currently accepting clients for the Depo Provera lawsuit.
A few reasons to choose TruLaw for your Depo-Provera lawsuit include:
If you or a loved one were diagnosed with any grade of meningioma or suffered from other severe health conditions after using Depo-Provera, you may be eligible to seek compensation.
Contact TruLaw using the chat on this page to receive an instant case evaluation that can determine if you qualify for the Depo Provera shot lawsuit today.
Most side effects begin to diminish within 3-6 months after your last injection.
However, some effects related to medroxyprogesterone injections may persist longer.
Menstrual irregularities typically resolve within a year, while bone density often improves gradually over 2-3 years.
Meningiomas related to hormone exposure may continue to grow even after discontinuation, requiring ongoing monitoring.
Most Depo Provera side effects are reversible, including:
However, meningioma tumors generally require medical intervention and may not regress spontaneously after stopping the medication.
In rare cases, very severe bone density loss might not fully reverse.
Serious side effects occur in a minority of users.
Research shows Depo-Provera users experience bone density loss at the hip of approximately 1.12% per year compared with 0.05% for non-users.
The FDA has required a black box warning about this potential bone density loss.
The risk of meningioma appears to be about 5.55 times higher in long-term users compared to non-users, though the absolute risk remains relatively low.
Calcium and vitamin D supplements may help support bone health while using Depo-Provera.
However, no supplements have been proven to reduce the risk of other side effects, including meningioma development.
Always consult a healthcare provider before starting any supplement regimen.
A March 2024 study found that users of Depo-Provera for one year or more faced a 5.55-fold increased risk of developing meningiomas requiring surgery.
Another study confirmed 53% greater odds of developing meningioma in users compared to non-users.
The risk appears dose-dependent, meaning longer use and higher cumulative doses further increase risk.
Most meningiomas (over 90%) are non-cancerous (benign).
However, even benign meningiomas can cause serious health issues by pressing on brain tissue, nerves, or blood vessels.
About 1-2% of meningiomas are classified as atypical, and less than 1% are malignant.
The best approach depends on tumor size, location, and individual health factors.
Meningioma treatment options typically include, but are not limited to:
Currently, routine brain scans aren’t recommended for all users without symptoms.
However, prompt medical evaluation is advised for persistent headaches, vision changes, or other neurological symptoms after receiving medroxyprogesterone injections.
Women who used Depo-Provera for one year or more might discuss screening options with their healthcare provider, as research shows risk increases after just one year of use.
TruLaw can provide an immediate case evaluation through the chat found on this page.
You may qualify for a Depo-Provera lawsuit if you:
Statutes of limitations vary by state, typically ranging from 1-3 years from either:
However, this can differ on a case by case basis – for that reason, it’s important to discuss the details of your situation with an experienced Depo Provera attorney.
They can help you understand how the statute of limitations will impact your case and ensure you do not miss any important deadlines.
If you or a loved one developed a meningioma after using Depo-Provera, you may be eligible to seek compensation.
Contact TruLaw using the chat on this page to receive an instant case evaluation and determine whether you qualify to join others in filing a Depo-Provera lawsuit today.
Managing Attorney & Owner
With over 25 years of legal experience, Jessica Paluch-Hoerman is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share the most reliable, accurate, and up-to-date legal information with our readers!
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TruLaw, we fiercely combat corporations that endanger individuals’ well-being. If you’ve suffered injuries and believe these well-funded entities should be held accountable, we’re here for you.
With TruLaw, you gain access to successful and seasoned lawyers who maximize your chances of success. Our lawyers invest in you—they do not receive a dime until your lawsuit reaches a successful resolution!
AFFF Lawsuit claims are being filed against manufacturers of aqueous film-forming foam (AFFF), commonly used in firefighting.
Claims allege that companies such as 3M, DuPont, and Tyco Fire Products failed to adequately warn users about the potential dangers of AFFF exposure — including increased risks of various cancers and diseases.
Depo Provera Lawsuit claims are being filed by individuals who allege they developed meningioma (a type of brain tumor) after receiving Depo-Provera birth control injections.
A 2024 study found that women using Depo-Provera for at least 1 year are five times more likely to develop meningioma brain tumors compared to those not using the drug.
Suboxone Tooth Decay Lawsuit claims are being filed against Indivior, the manufacturer of Suboxone, a medication used to treat opioid addiction.
Claims allege that Indivior failed to adequately warn users about the potential dangers of severe tooth decay and dental injuries associated with Suboxone’s sublingual film version.
Social Media Harm Lawsuits are being filed against social media companies for allegedly causing mental health issues in children and teens.
Claims allege that companies like Meta, Google, ByteDance, and Snap designed addictive platforms that led to anxiety, depression, and other mental health issues without adequately warning users or parents.
Transvaginal Mesh Lawsuits are being filed against manufacturers of transvaginal mesh products used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI).
Claims allege that companies like Ethicon, C.R. Bard, and Boston Scientific failed to adequately warn about potential dangers — including erosion, pain, and infection.
Bair Hugger Warming Blanket Lawsuits involve claims against 3M — alleging their surgical warming blankets caused severe infections and complications (particularly in hip and knee replacement surgeries).
Plaintiffs claim 3M failed to warn about potential risks — despite knowing about increased risk of deep joint infections since 2011.
Baby Formula NEC Lawsuit claims are being filed against manufacturers of cow’s milk-based baby formula products.
Claims allege that companies like Abbott Laboratories (Similac) and Mead Johnson & Company (Enfamil) failed to warn about the increased risk of necrotizing enterocolitis (NEC) in premature infants.
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?